India · Delayed Price · Currency is INR Novartis India Statistics
Total Valuation
Novartis India has a market cap or net worth of INR 40.23 billion. The enterprise value is 33.58 billion.
| Market Cap | 40.23B |
| Enterprise Value | 33.58B |
Important Dates
The last earnings date was Thursday, July 23, 2026.
| Earnings Date | Jul 23, 2026 |
| Ex-Dividend Date | Jul 23, 2025 |
Share Statistics
Novartis India has 24.69 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 24.69M |
| Shares Outstanding | 24.69M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.60% |
| Float | 6.70M |
Valuation Ratios
The trailing PE ratio is 41.14.
| PE Ratio | 41.14 |
| Forward PE | n/a |
| PS Ratio | 10.85 |
| PB Ratio | 4.92 |
| P/TBV Ratio | 4.92 |
| P/FCF Ratio | 86.71 |
| P/OCF Ratio | 86.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.84, with an EV/FCF ratio of 72.39.
| EV / Earnings | 34.35 |
| EV / Sales | 9.06 |
| EV / EBITDA | 32.84 |
| EV / EBIT | 33.60 |
| EV / FCF | 72.39 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.07 |
| Interest Coverage | 81.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 46.98% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.71% |
| Revenue Per Employee | 66.18M |
| Profits Per Employee | 17.46M |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Novartis India has paid 378.40 million in taxes.
| Income Tax | 378.40M |
| Effective Tax Rate | 27.90% |
Stock Price Statistics
The stock price has increased by +61.69% in the last 52 weeks. The beta is 0.26, so Novartis India's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +61.69% |
| 50-Day Moving Average | 1,446.78 |
| 200-Day Moving Average | 1,022.90 |
| Relative Strength Index (RSI) | 59.98 |
| Average Volume (20 Days) | 4,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis India had revenue of INR 3.71 billion and earned 977.70 million in profits. Earnings per share was 39.60.
| Revenue | 3.71B |
| Gross Profit | 1.63B |
| Operating Income | 999.30M |
| Pretax Income | 1.36B |
| Net Income | 977.70M |
| EBITDA | 1.02B |
| EBIT | 999.30M |
| Earnings Per Share (EPS) | 39.60 |
Balance Sheet
The company has 6.68 billion in cash and 32.10 million in debt, with a net cash position of 6.64 billion or 269.12 per share.
| Cash & Cash Equivalents | 6.68B |
| Total Debt | 32.10M |
| Net Cash | 6.64B |
| Net Cash Per Share | 269.12 |
| Equity (Book Value) | 8.18B |
| Book Value Per Share | 331.34 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 467.30 million and capital expenditures -3.40 million, giving a free cash flow of 463.90 million.
| Operating Cash Flow | 467.30M |
| Capital Expenditures | -3.40M |
| Depreciation & Amortization | 23.20M |
| Net Borrowing | -22.00M |
| Free Cash Flow | 463.90M |
| FCF Per Share | 18.79 |
Margins
Gross margin is 44.07%, with operating and profit margins of 26.97% and 26.38%.
| Gross Margin | 44.07% |
| Operating Margin | 26.97% |
| Pretax Margin | 36.59% |
| Profit Margin | 26.38% |
| EBITDA Margin | 27.59% |
| EBIT Margin | 26.97% |
| FCF Margin | 13.09% |
Dividends & Yields
This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 1.54%.
| Dividend Per Share | 25.00 |
| Dividend Yield | 1.54% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | 1.52% |
| Earnings Yield | 2.43% |
| FCF Yield | 1.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |